Trial Profile
A retrospective study of Tc-99 tilmanocept to evaluate node-positivity rate, and number of total nodes in breast cancer patients undergoing sentinel lymph node (SLN) biopsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Mar 2016
Price :
$35
*
At a glance
- Drugs Tc 99m tilmanocept (Primary)
- Indications Breast cancer
- Focus Diagnostic use
- 18 Mar 2016 New trial record